SEVERE COMBINED IMMUNODEFICIENCY SCREENING AND STEM CELL TRANSPLANT-AN ECONOMIC EVALUATION SCHEME
- Consultant of Family Medicine & Public Health, Ministry of Health, Jeddah, Saudi Arabia.
- Associated Professor of Family Medicine, Taif University, Taif, Saudi Arabia.
- Laparoscopic and Thoracic Surgeon, Taif University, Taif, Saudi Arabia.
- General Practitioner, King Abdullah Medical Complex, Ministry of Health, Jeddah, Saudi Arabia.
Abstract
Background: Severe Combined Immunodeficiency (SCID) is a rare genetic disease that affects newborn immune system and costs healthcare system a substantial amount of money. Screening and stem cell transplant may offer a cost-effective alternative to the current medical practice.
Objective: To determine the cost-effectiveness of screening newborn for SCID with subsequent stem cell transplant versus standard of care.
Materials and Methods: An economic evaluation was proposed, using Treeage software on a set of evidence-based propabilities and variables.
Outcomes: as shown on the tree, we count the death from SCID. Its given the payoff 1, while the survival is payoff 0. The outcome of interest is death averted by screening live birth and implementing subsequent stem cell transplant for those who tested +ve.
Article Analytics
How to Cite This Article
Husain Ahmed Alzobaidi, Abdul Rhman Alghamdi, Mohammad Eid Mahfouz and Rawan Dakeel Allah Alsubhi (2021); SEVERE COMBINED IMMUNODEFICIENCY SCREENING AND STEM CELL TRANSPLANT-AN ECONOMIC EVALUATION SCHEME, Int. J. of Adv. Res., 9 (11), 966-969, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/13829
Corresponding Author
This work is licensed under a Creative Commons Attribution 4.0 International License.